Synovics Operating Cycle from 2010 to 2026
| SYVC Stock | USD 0.0001 0.00 0.00% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 133.47 | Current Value 126.8 | Quarterly Volatility 78.70724453 |
Check Synovics Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Synovics Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 6.7 M or Total Revenue of 31.3 M, as well as many indicators such as Price To Sales Ratio of 1.0E-4, Dividend Yield of 0.0 or PTB Ratio of 4.0E-4. Synovics financial statements analysis is a perfect complement when working with Synovics Pharmaceuticals Valuation or Volatility modules.
Synovics | Operating Cycle | Build AI portfolio with Synovics Stock |
Latest Synovics Pharmaceuticals' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Synovics Pharmaceuticals over the last few years. It is Synovics Pharmaceuticals' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Synovics Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Synovics Operating Cycle Regression Statistics
| Arithmetic Mean | 136.87 | |
| Geometric Mean | 127.25 | |
| Coefficient Of Variation | 57.50 | |
| Mean Deviation | 35.87 | |
| Median | 116.06 | |
| Standard Deviation | 78.71 | |
| Sample Variance | 6,195 | |
| Range | 326 | |
| R-Value | (0.38) | |
| Mean Square Error | 5,669 | |
| R-Squared | 0.14 | |
| Significance | 0.14 | |
| Slope | (5.88) | |
| Total Sum of Squares | 99,117 |
Synovics Operating Cycle History
About Synovics Pharmaceuticals Financial Statements
Synovics Pharmaceuticals stakeholders use historical fundamental indicators, such as Synovics Pharmaceuticals' Operating Cycle, to determine how well the company is positioned to perform in the future. Although Synovics Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Synovics Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Synovics Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Synovics Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 133.47 | 126.80 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Synovics Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Synovics Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Synovics Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Synovics Pharmaceuticals Stock:Check out the analysis of Synovics Pharmaceuticals Correlation against competitors. For information on how to trade Synovics Stock refer to our How to Trade Synovics Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synovics Pharmaceuticals. If investors know Synovics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synovics Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Synovics Pharmaceuticals is measured differently than its book value, which is the value of Synovics that is recorded on the company's balance sheet. Investors also form their own opinion of Synovics Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Synovics Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synovics Pharmaceuticals' market value can be influenced by many factors that don't directly affect Synovics Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synovics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synovics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synovics Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.